Literature DB >> 2020257

Plasma endothelin levels during myocardial ischemia and reperfusion.

S Tsuji1, A Sawamura, H Watanabe, K Takihara, S E Park, J Azuma.   

Abstract

Endothelin, an endothelium-derived vasoconstrictive peptide, has a strong potency of coronary artery constriction. However, the role of endogeneous endothelin under pathophysiological conditions has not yet been known. In this study, we examined plasma endothelin concentration in dogs with myocardial ischemia and reperfusion. Anesthetized open-chest dogs underwent either 45 minutes occlusion of the left anterior descending coronary artery followed by 3 hours reperfusion, or 4-10 hours of continuous occlusion. Plasma concentration of endothelin from the central vein was measured by the highly sensitive enzyme-immunoassay. Plasma endothelin concentration increased 2.2-fold with the peak level at 60 minutes after release of the ligated artery, but occlusion per se caused no remarkable change. These data suggest that reperfusion of the occluded artery might be needed to increase the plasma concentration of endothelin in case of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020257     DOI: 10.1016/0024-3205(91)90211-s

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance.

Authors:  A Ergul; C Joffs; A C Walker; F G Spinale
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  Inhibition of granulocyte-derived proteases reduces the increase in plasma endothelin associated with myocardial ischemia in the pig.

Authors:  T Tønnessen; A Ilebekk; P A Naess; G Christensen
Journal:  Basic Res Cardiol       Date:  1996 Jul-Aug       Impact factor: 17.165

3.  Association of endothelin with lung hemorrhage induced by immune complexes in rats.

Authors:  C F P Teixeira; S Jancar; W T Lima; P D'Orléans-Juste; P Sirois
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

4.  Mechanisms underlying capsaicin effects in canine coronary artery: implications for coronary spasm.

Authors:  S Christopher Hiett; Meredith K Owen; Wennan Li; Xingjuan Chen; Ashley Riley; Jillian Noblet; Sarah Flores; Michael Sturek; Johnathan D Tune; Alexander G Obukhov
Journal:  Cardiovasc Res       Date:  2014-06-15       Impact factor: 10.787

5.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

6.  Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.

Authors:  V Richard; N Kaeffer; M Hogie; C Tron; T Blanc; C Thuillez
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 7.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

8.  Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure.

Authors:  Junlan Zhou; Neha Singh; Chloe Monnier; William Marszalec; Li Gao; Jing Jin; Michael Frisk; William E Louch; Suresh Verma; Prasanna Krishnamurthy; Elsa Nico; Maaz Mulla; Gary L Aistrup; Raj Kishore; J Andrew Wasserstrom
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

9.  Endothelin-B Receptors and Left Ventricular Dysfunction after Regional versus Global Ischaemia-Reperfusion in Rat Hearts.

Authors:  Sofia-Iris Bibli; Eleni V Toli; Agapi D Vilaeti; Varnavas C Varnavas; Giannis G Baltogiannis; Apostolos Papalois; Zenon S Kyriakides; Theofilos M Kolettis
Journal:  Cardiol Res Pract       Date:  2012-07-12       Impact factor: 1.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.